Catalent Pharma Solutions
在场
是其中之一......
Catalent Pharma Solutions 是一家在股票代码 CTLT (US) 下上市的公司。
Catalent Pharma Solutions 在 2 个国家有直接业务。Catalent Pharma Solutions 拥有 3家子公司，其中包括 Catalent Biologics、Catalent Cell & Gene Therapy 和 Catalent Pharma Germany。
他们在：
涉及Catalent Pharma Solutions的并购和融资。
- Novo Holdings has announced the acquisition of Catalent Pharma Solutions (公布2024二月8号).
高管
查看带有其 51 名主要高管的组织结构图
Catalent Pharma Solutions 搜索最多的简介
- Alessandro Maselli, President and Chief Executive Officer
- Jack Stahl, Board Member and Lead Director
- Michael Barber, Board Member
创建提醒
跟踪 Catalent Pharma Solutions 的高管变动
医疗设备
Catalent Pharma Solutions 拥有 991 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。
Popular M&A news in 医疗设备
- ShiraTronics 刚刚宣布为 66 筹款数百万美元。 (公布2024十月23号).
- Johnson & Johnson 已收购 V-Wave (公布2024十月9号).
- Biolase Technology has filed for bankruptcy protection Biolase Technology (公布2024十月2号).
医疗设备 行业的其他推荐联系人
消息
Catalent Pharma Solutions 的最新新闻稿
- IsomAb Announces Strategic Collaboration with Catalent
- Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility
- Catalent Completes Expansion of Clinical Supply Facility
- Catalent Publishes Fifth Annual Corporate Responsibility Report
- Catalent Adds Potent Capsule Filling Capabilities for Inhaled Dry Powders at its Boston Facility
- Novo Holdings to Acquire Catalent | Catalent Pharma Solutions
- Catalent Commits to Reducing Greenhouse Gas Emissions by 2030
- Catalent Appoints David McErlane as Biologics Segment Leader
- Catalent Appoints Lisa Evoli Senior Vice President and Chief Human Resource Officer
- Catalent Appoints New Senior Vice President & Chief Financial Officer
- View more press releases Close
通过电子邮件
